APA (7th ed.) Citation

Kharfan-Dabaja, M. A., Labopin, M., Bazarbachi, A., Hamladji, R. M., Blaise, D., Socié, G., . . . Mohty, M. (2014). Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: A report from the Acute Leukemia Working Party of EBMT. Bone Marrow Transplantation, 49(9), 1170. https://doi.org/10.1038/bmt.2014.133

Chicago Style (17th ed.) Citation

Kharfan-Dabaja, M A., et al. "Comparing I.v. BU Dose Intensity Between Two Regimens (FB2 Vs FB4) for Allogeneic HCT for AML in CR1: A Report from the Acute Leukemia Working Party of EBMT." Bone Marrow Transplantation 49, no. 9 (2014): 1170. https://doi.org/10.1038/bmt.2014.133.

MLA (9th ed.) Citation

Kharfan-Dabaja, M A., et al. "Comparing I.v. BU Dose Intensity Between Two Regimens (FB2 Vs FB4) for Allogeneic HCT for AML in CR1: A Report from the Acute Leukemia Working Party of EBMT." Bone Marrow Transplantation, vol. 49, no. 9, 2014, p. 1170, https://doi.org/10.1038/bmt.2014.133.